Canopy sues GW Pharma over cannabis patent

24-12-2020

Muireann Bolger

Canopy sues GW Pharma over cannabis patent

Aleksandr Kurganov / Shutterstock.com

Canadian medical cannabis company Canopy Growth has accused GW Pharma of using a patented technological process to produce its flagship epilepsy treatment, Epidiolex, without authorisation.


Canopy, Epidiolex, GW Pharma, CBD treatment, epilepsy, epilepsy treatment, Epidiolex, patent infringement, medical cannabis

LSIPR